COVID-19 Impact on Global Medical Foods for Inborn Errors of Metabolism Market Insights and Forecast to 2026

1 Study Coverage

• 1.1 Medical Foods for Inborn Errors of Metabolism Product Introduction
• 1.2 Market Segments
• 1.3 Key Medical Foods for Inborn Errors of Metabolism Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Type
  • 1.4.2 Amino Acid
  • 1.4.3 Glytactin with GMP
  • 1.4.4 Amino Acid-Modified Infant Formula With Iron
  • 1.4.5 Low Protein Food
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Medical Foods for Inborn Errors of Metabolism Market Size Growth Rate by Application
  • 1.5.2 Phenylketonuria (PKU)
  • 1.5.3 Maple Syrup Urine Disease (MSUD)
  • 1.5.4 Urea Cycle Disorders
  • 1.5.5 Renal Disease
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Medical Foods for Inborn Errors of Metabolism Market Size, Estimates and Forecasts
  • 2.1.1 Global Medical Foods for Inborn Errors of Metabolism Revenue 2015-2026
  • 2.1.2 Global Medical Foods for Inborn Errors of Metabolism Sales 2015-2026
• 2.2 Global Medical Foods for Inborn Errors of Metabolism, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Medical Foods for Inborn Errors of Metabolism Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Medical Foods for Inborn Errors of Metabolism Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Medical Foods for Inborn Errors of Metabolism Competitor Landscape by Players

• 3.1 Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers
  • 3.1.1 Medical Foods for Inborn Errors of Metabolism Sales by Manufacturers (2015-2020)
  • 3.1.2 Medical Foods for Inborn Errors of Metabolism Sales Market Share by Manufacturers (2015-2020)
• 3.2 Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers
  • 3.2.1 Medical Foods for Inborn Errors of Metabolism Revenue by Manufacturers (2015-2020)
  • 3.2.2 Medical Foods for Inborn Errors of Metabolism Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Medical Foods for Inborn Errors of Metabolism Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Medical Foods for Inborn Errors of Metabolism Revenue in 2019
  • 3.2.5 Global Medical Foods for Inborn Errors of Metabolism Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Medical Foods for Inborn Errors of Metabolism Price by Manufacturers
• 3.4 Medical Foods for Inborn Errors of Metabolism Manufacturing Base Distribution, Product Types
  • 3.4.1 Medical Foods for Inborn Errors of Metabolism Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Medical Foods for Inborn Errors of Metabolism Product Type
  • 3.4.3 Date of International Manufacturers Enter into Medical Foods for Inborn Errors of Metabolism Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Medical Foods for Inborn Errors of Metabolism Market Size by Type (2015-2020)
  • 4.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Type (2015-2020)
  • 4.1.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Type (2015-2020)
  • 4.1.3 Medical Foods for Inborn Errors of Metabolism Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Type (2021-2026)
  • 4.2.3 Medical Foods for Inborn Errors of Metabolism Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Medical Foods for Inborn Errors of Metabolism Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Medical Foods for Inborn Errors of Metabolism Market Size by Application (2015-2020)
  • 5.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales by Application (2015-2020)
  • 5.1.2 Global Medical Foods for Inborn Errors of Metabolism Revenue by Application (2015-2020)
  • 5.1.3 Medical Foods for Inborn Errors of Metabolism Price by Application (2015-2020)
• 5.2 Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Medical Foods for Inborn Errors of Metabolism Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Medical Foods for Inborn Errors of Metabolism by Country
  • 6.1.1 North America Medical Foods for Inborn Errors of Metabolism Sales by Country
  • 6.1.2 North America Medical Foods for Inborn Errors of Metabolism Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
• 6.3 North America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

7 Europe

• 7.1 Europe Medical Foods for Inborn Errors of Metabolism by Country
  • 7.1.1 Europe Medical Foods for Inborn Errors of Metabolism Sales by Country
  • 7.1.2 Europe Medical Foods for Inborn Errors of Metabolism Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
• 7.3 Europe Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism by Region
  • 8.1.1 Asia Pacific Medical Foods for Inborn Errors of Metabolism Sales by Region
  • 8.1.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
• 8.3 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Medical Foods for Inborn Errors of Metabolism by Country
  • 9.1.1 Latin America Medical Foods for Inborn Errors of Metabolism Sales by Country
  • 9.1.2 Latin America Medical Foods for Inborn Errors of Metabolism Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
• 9.3 Central & South America Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism by Country
  • 10.1.1 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Sales by Country
  • 10.1.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Type
• 10.3 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Facts & Figures by Application

11 Company Profiles

• 11.1 Nestlé
  • 11.1.1 Nestlé Corporation Information
  • 11.1.2 Nestlé Description and Business Overview
  • 11.1.3 Nestlé Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.1.5 Nestlé Related Developments
• 11.2 Abbott
  • 11.2.1 Abbott Corporation Information
  • 11.2.2 Abbott Description and Business Overview
  • 11.2.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Abbott Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.2.5 Abbott Related Developments
• 11.3 Reckitt Benckiser Group
  • 11.3.1 Reckitt Benckiser Group Corporation Information
  • 11.3.2 Reckitt Benckiser Group Description and Business Overview
  • 11.3.3 Reckitt Benckiser Group Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Reckitt Benckiser Group Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.3.5 Reckitt Benckiser Group Related Developments
• 11.4 Ajinomoto
  • 11.4.1 Ajinomoto Corporation Information
  • 11.4.2 Ajinomoto Description and Business Overview
  • 11.4.3 Ajinomoto Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Ajinomoto Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.4.5 Ajinomoto Related Developments
• 11.5 Solace Nutrition
  • 11.5.1 Solace Nutrition Corporation Information
  • 11.5.2 Solace Nutrition Description and Business Overview
  • 11.5.3 Solace Nutrition Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Solace Nutrition Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.5.5 Solace Nutrition Related Developments
• 11.6 Primus Pharmaceuticals
  • 11.6.1 Primus Pharmaceuticals Corporation Information
  • 11.6.2 Primus Pharmaceuticals Description and Business Overview
  • 11.6.3 Primus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Primus Pharmaceuticals Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.6.5 Primus Pharmaceuticals Related Developments
• 11.7 BioMarin Pharmaceutical
  • 11.7.1 BioMarin Pharmaceutical Corporation Information
  • 11.7.2 BioMarin Pharmaceutical Description and Business Overview
  • 11.7.3 BioMarin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 BioMarin Pharmaceutical Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.7.5 BioMarin Pharmaceutical Related Developments
• 11.8 Danone SA
  • 11.8.1 Danone SA Corporation Information
  • 11.8.2 Danone SA Description and Business Overview
  • 11.8.3 Danone SA Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 Danone SA Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.8.5 Danone SA Related Developments
• 11.9 Galen Limited
  • 11.9.1 Galen Limited Corporation Information
  • 11.9.2 Galen Limited Description and Business Overview
  • 11.9.3 Galen Limited Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Galen Limited Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.9.5 Galen Limited Related Developments
• 11.10 PKU-MDMIL
  • 11.10.1 PKU-MDMIL Corporation Information
  • 11.10.2 PKU-MDMIL Description and Business Overview
  • 11.10.3 PKU-MDMIL Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 PKU-MDMIL Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.10.5 PKU-MDMIL Related Developments
• 11.1 Nestlé
  • 11.1.1 Nestlé Corporation Information
  • 11.1.2 Nestlé Description and Business Overview
  • 11.1.3 Nestlé Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Nestlé Medical Foods for Inborn Errors of Metabolism Products Offered
  • 11.1.5 Nestlé Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Medical Foods for Inborn Errors of Metabolism Market Estimates and Projections by Region
  • 12.1.1 Global Medical Foods for Inborn Errors of Metabolism Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Medical Foods for Inborn Errors of Metabolism Revenue Forecast by Regions 2021-2026
• 12.2 North America Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
  • 12.2.1 North America: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
  • 12.2.2 North America: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
  • 12.2.3 North America: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)
• 12.3 Europe Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
  • 12.3.2 Europe: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Medical Foods for Inborn Errors of Metabolism Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Medical Foods for Inborn Errors of Metabolism Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Medical Foods for Inborn Errors of Metabolism Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Medical Foods for Inborn Errors of Metabolism Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Medical Foods for Inborn Errors of Metabolism Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Medical Foods for Inborn Errors of Metabolism Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details